Your company is already operating in Germany and you would now like to export worldwide?
Deadline Extension
Deadline: Apr 19, 2024
Financing: KfW Entwicklungsbank
Requested services:
Procurement, supply, delivery, installation, testing and commissioning of pressure swing adsorption plants (PSA) for medical centers.
Deadline: Jul 02, 2024
Financing: KfW Entwicklungsbank
Requested Services:
Supply of equipment and material for SME support as part of the project for capacity development in the field of training for health care specialists and technicians
Cancellation Notice KfW
Financing: KfW Entwicklungsbank
CANCELLATION OF TENDER
Requested Services
The African Union (AU) aims to vaccinate 60 % of the entire African population. In order to prepare investments along the entire value chain of vaccine manufacturing and the manufacturing of other medical and pharmaceutical products and their respective accessory products, the Afreximbank has received grant financing from KfW. The Consultant is expected to work in close cooperation with Afreximbank and to support the management of the prep4vac project. In...
Germany’s healthcare sector enjoyed a successful year with a resurgent biotech sector generating a quarter of new capital. New therapies are being developed for a range of autoimmune diseases and telemedicine service are on the rise.
The injectable Mounjaro that will be mass produced by Eli Lilly and Company in Germany has been cleared for use in helping people shed pounds.
In 2023, there was a notable resurgence in the financing available to Germany's biotechnology sector.
Germany is undertaking a “digital revolution” in healthcare and now has a strategy to make life easier for pharmaceutical companies.
American pharmaceutical company Lilly will construct a USD 2.5 billion high-tech production site in Alzey in the west of Europe’s largest healthcare market.
MEDICA 2023, the world-leading information and communication platform for the medical technology industry and supplier industry took place in November.
Innovative start-ups are booming in Germany's attractive life sciences sector.
